.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chill Medicated has shown varying performance across different categories and states. In Massachusetts, the brand's presence in the Beverage category has experienced a slight decline in rankings from 4th place in both June and July to 5th place in August and September. This downward trend is mirrored by a decrease in sales from $153,586 in June to $110,901 by September. In the Tincture & Sublingual category, Chill Medicated entered the top 30 brands in September, achieving a 6th place ranking, which indicates a positive movement into this category. The Topical category also saw fluctuations, with the brand holding a strong 2nd place in June and August but dropping to 3rd place in July and September, showing some volatility in its market position.
In Michigan, Chill Medicated has maintained a consistent presence in the Beverage category, holding steady at 8th place from June through August, before slipping to 9th in September. Despite this slight drop in ranking, sales in this category have shown a positive trend, increasing from $54,234 in June to $70,504 in September. The Topical category in Michigan presents a compelling success story for Chill Medicated, as the brand has consistently held the top rank from June through September, showcasing its dominance and strong consumer preference in this category. This sustained top position is complemented by robust sales figures, although there was a slight dip from August to September, which may warrant further observation in future months.
Competitive Landscape
In the Michigan topical cannabis market, Chill Medicated has consistently maintained its leading position from June to September 2025, outperforming its competitors in both rank and sales. Despite strong competition, Chill Medicated's sales figures have remained robust, with a noticeable upward trend in sales from June through August, before a slight dip in September. This consistent performance keeps it ahead of Mary's Medicinals, which holds a steady second place with sales figures significantly lower than Chill Medicated's, although they experienced a peak in August. Meanwhile, Rise (MI) remains in third place, with a downward trend in sales over the same period, indicating a widening gap between it and the leading brands. Chill Medicated's ability to sustain its top rank amidst these dynamics highlights its strong market presence and consumer preference in the Michigan topical category.
Notable Products
In September 2025, the CBD/THC 1:1 Extreme X Body Rub (2000mg CBD, 2000mg THC, 2.5oz) maintained its top position as the best-selling product for Chill Medicated, with sales reaching 4712 units. The Maxx - CBD/THC 1:1 Medicated Body Rub (1000mg CBD, 1000mg THC, 2.5oz) secured the second spot, recovering from a temporary dip to third place in August. Cherry Syrup (200mg THC, 4floz) climbed to third place, showing a notable increase in popularity since its introduction in July. Grape Syrup (200mg) slipped to fourth place, despite a steady increase in sales over the months. Strawberry Syrup (200mg) remained consistent in fifth place, maintaining its rank from August.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
